Nouvelles approches synthétiques de prodrogues de cyclosporine A et d'analogues antiviraux

The cyclosporins comprise a family of cyclic 11-peptides containing seven N-methylated, hydrophobic amino acids. Cyclosporine A (CsA) representing the major member of this family is widely used as immunosuppressive agent in organ transplantations. The biological activity resides in the cells of lymphocytes T forming in a first step a binary complex with cyclophilin A (CyPA), which transforms to a ternary complex in binding to a second receptor molecule, i.e calcineurin (CN). The formation of a ternary complex results in an inhibition of a dephosphorylation step of transcription factor NFAT, preventing the translocation of NFAT needed for T-cell activation. More recently it was found that CyPA acts in addition as ligand for polyprotein gag pr55 liberated by the capsid of the virus HIV, stimulating the production of the virus. In complexing to CsA, this step is prevented, blocking the bio-synthetic pathway for the HIV reproduction. In previous research work of the Mutter group, CsA has been transformed by chemical synthesis to non-immunosuppressive, anti-viral analogues as potential drugs against AIDS. Based on these studies, the present PhD thesis aims to overcome some major limitations in the application and further exploration of structure-activity-relationship (SAR) studies of pharmaceutically interesting CsA analogues. The low bioavaibility of CsA results from its hydrophobic character combined with low water solubility. For overcoming this problem, the first part of the present thesis elaborates novel types of prodrug systems based on the recently developed concept of "switch-peptides" (M.Mutter et al., Angew.Chem., 2004). To this end, CsA is transformed to O-isoacyl-CsA derivatives featuring a selectively cleavable amino-protecting group Y (figure 1), resulting in a stable, highly soluble prodrug devoid of any biological activity (Soff state). The transformation into the active compound (Son state) can be triggered at physiological conditions by the photolytic or enzymatic cleavage of Y, followed by spontaneous O to N acyl migration. By the introduction of linkers in the enzymatically cleavable system, the transformation of the prodrug into the native compound can be modulated over a broad time interval, i.e between minutes and several hours. Interestingly, the use of photocleavable groups results in completely stable prodrug systems (Soff state), whereas the structurally more demanding enzymatically cleavable systems show strongly increased water solubility, but reduced thermodynamic stability. Figure 1: CsA as prodrug applying the concept of "switch-peptides" The elaborated systems can be transferred to analogues of CsA containing Ser, Thr or Cys residues at specific positions. As a most promising candidate for exploring antiviral, non-immunosuppressive properties, we focus in the second part of the thesis on the synthesis of functional CsA analogues at position 8 by N-alkylation reactions. Previous studies by O.Turpin (PhD thesis 2004, EPFL) have shown, that the differential reactivity of the non N-methylated sites in CsA allows for a selective introduction of functional groups. Scheme 1: Strategy for the synthesis of linear precursor molecules of (Axx8)-CsA By applying optimized methodologies as outlined in Scheme 1, i.e selective N-alkylation at position 8 (step 1), rearrangement reaction (2), ring opening step and Edman degradation (3), we succeeded in overall yields of the linear decapeptide up to 25 % as versatile precursor molecule. Most notably, key step 1 proceeded in high yields, allowing for direct chemical derivatisations within the CN-binding site. In conclusion, the elaboration of synthetic pathways to novel prodrug systems ("switch-peptides") in combination with a selective access to CsA analogues modified at the calcineurin-binding site offers new perspectives in the design of cyclophilin inhibitors of high therapeutical relevance.

"Switch peptides"

Lydiane Jeanine Saucède

Despite of considerable progress in the research at the interface of Chemistry, Biology and Medicine, neurodegenerative diseases affect more and more seriously our ageing population and remain a real therapeutic challenge for researcher. Nevertheless, advances made in this field allow us to better understand the molecular mechanisms responsible for these disorders and to stress the involvement and the key-role of conformational changes of some proteins. Thought to be at the origin of Alzheimer's disease, amyloid-β peptide undergoes structural modifications leading to β-sheet structures, which further aggregate into toxic fibrils and plaques. However, intrinsic properties of these structures result in problems such as insolubility and self-aggregation limiting their experimental access. Among the main research lines to find an efficient therapeutic agent to fight against Alzheimer's disease, fibrillar inhibition is considered as promising strategy. It requires the use of a molecule, called β-breaker, which would be able to block the misfolding triggered by conformational transitions. Consequently, the present thesis is focusing on the design and chemical synthesis of potential inhibitors of amyloid-β fibrillogenesis. As a specific common feature, the designed compounds integrate in their chemical structure a short sequence ("nucleation site") derived from the central part of Aβ(1-42), allowing to specifically interact with the pathogenic peptide. We first envisaged to design cyclic peptides as potential inhibitors containing proline residues, known for its destabilizing effect upon secondary structures (way A). In collaboration with C. Soto et al., Univ. Galveston, the biological activity of the prototype cyclo(Lys-Leu-Pro-Phe-Phe-Glu) was tested. Most notably, electron microscopy, in collaboration with J. Dubochet and M. Adrian, UNIL, Congo red and thioflavin T staining, and CD studies pointed to the potential of cyclic peptides as Aβ inhibitors. Subsequently, conjugate peptides, assembling the recognition sequence of amyloid-β and organic molecules with potential to block fibrillogenesis were synthesized specifically. (+/-)-Trans-4-cotininecarboxylic acid, 3-indolebutyric acid and a tripeptide β-strand mimic were chosen. The biological assessment of these molecules allowed us to highlight their potential in this therapeutic strategy as well as the advantage given by the intercalation of a proline between the two components of these conjugates. In an effort to introduce in the structure of β-breakers a dynamization element, comparable to the cis/trans isomerization of proline, we designed a new type of β-breaking molecules according to strategy B (Figure). The elaboration of this innovating concept termed "switch-peptides" allows to controll the function of a polypeptide by using intramolecular acyl migration as switch-element for the in situ induction of structure and function. By combining an conformational induction unit σ, a switch element S (cysteine or serine) and an amyloid recognition sequence, we obtained a new generation of dynamic β-breakers. At the Soff state, the σ part was linked to the switch element S via an ester bond, deactivating the structural influence of the conformational induction unit on the target peptide, resulting in the absence of biological activity. By removing the protecting group Y from the amino function of the switch element, intramolecular acyl migration was triggered, restoring the native amide bond, setting off the impact of σ (Son state). In applying pseudo-prolines as β-breaking σ-elements (resulting in a "kink" conformation), the corresponding switch-peptide can adopt a recognition state (Soff) and a β-sheet disrupting state (Son), triggered by controlled acyl migration. We explored the use of cysteine as switch element, with special attention to the chemoselective synthesis, kinetics of acyl migration and potential for β-breaking. Interestingly, the S→N acyl migration proceeded very fast at physiological pH, in comparison to serine derived O→N migrations. Of utmost importance for further extensions of the switch-concept, the design of non peptidic S-elements such as trifunctionalized aromatic compounds would allow us to generate the β-breaking element in situ. As a first step, the intramolecular acyl migration O→N via an intermediate of 5, 6, 7 or 9 membered rings, as well as the reversibility of this reaction, was successfully demonstrated. In addition, enzymatically cleavable protecting groups Y for triggering acyl migrations were established. In conclusion, the present thesis presents some promising concepts in the design of fibril disrupting compounds of considerable therapeutical potential.

EPFL2006

Switch-peptides: controlling biological function and self-assembly of amyloid ß-derived peptides using enzyme-triggered acyl migrations

Sonia Dos Santos

Conformational transitions of peptides and proteins have recently moved to the center of interest in various domains of research at the interface of chemistry, biology, and medicine due to their implication in an increasing number of diseases in which the pathogenesis is causally linked to the misfolding of a protein. For example, the amyloid β protein linked to Alzheimer's disease undergoes various conformational transitions, eventually leading to the formation of self-associating β-sheets, which in turn give rise to insoluble, fibrillar aggregates. Consequently, studies of such proteins are hampered by problems of solubility and often yield contradictory results. With the aim of surmounting these difficulties in the study of conformational transitions of peptides and proteins, a novel tool based on the concept of "Switch-Peptides" enabling the in situ induction of peptide folding will be elaborated in the present thesis. As shown in the Scheme, N(Y)-protected switch-peptides serve as stable, self-contained precursor molecules, in which folding and self-assembly is blocked by the presence of Ser or Thr derived switch-elements S, dissecting the regular peptide backbone by an ester and a flexible C-C bond. Removal of the protecting group Y triggers a spontaneous acyl migration that restores the native polypeptide chain ("statu nascendi") setting off the folding process. The body of work presented herein consists of two main themes: With the goal of developing a system amenable to physiological conditions, the introduction and evaluation of different, enzymatically cleavable Y groups was conceived. For proof of concept, the biologically active peptides angiotensin and neuropeptide Y were used, allowing the study of the impact of the S-element on their biological activities. Investigations of the analogue [Thr]5-Ang II containing a pH-triggered switch (Y = H+) reveal that the acyl migrations are very fast, exhibiting half-lives of less than one minute. With the introduction of enzymatically labile Y groups, specifically an Arg-Pro dipeptide (cleavable by dipeptidyl aminopeptidase) or the amino acid pGlu (cleavable by pyroglutamate aminopeptidase), rates of conversion ranging from minutes to hours are observed as monitored by HPLC, NMR and CD. Problems of steric interference associated with the action of enzymes such as esterases and penicillin amidase were overcome by developing linkers of different structural features. D-aminopeptidase (Y = D-Ala) was shown to extend the rates of enzymatic cleavage to half-lives of several days. The enzymes studied display high specificity for the switch-peptide substrates and a quantitative conversion from the Soff to the Son state. We took advantage of the affinity of Ang II and NPY for their respective receptors (AT2 and Y1) to show that their switch-peptide analogs are inactive in the Soff state where as after enzymatically triggered acyl migration, the peptides display high receptor affinity (IC50 = 45 nM for Ang II and IC50 = 5 nM for NPY). In the case of NPY, a conformational transition from a random coil to an α-helix as bioactive conformation is observed by CD. The second part of the work is dedicated to conformational transitions of type random coil → β-sheet in different model peptides or peptides derived from Aβ(1-42). All peptides studied show high potential for self-association and subsequent precipitation. However, in the Soff state, the switch-peptides display a high degree of stability and strongly enhanced aqueous solubility. After enzymatic triggering of the acyl migration, a conformational transition to a β-sheet accompanied by the formation of fibrils and spontaneous precipitation are observed by CD and EM studies. Based on the elaborated systems, the introduction of several orthogonal S-elements in Aβ derived peptides was realized. The incorporation of two different S-elements into the Aβ(1-42) sequence was found to greatly facilitate the normally difficult synthesis, and enabled the study of the influence of the individual peptide segments on the overall folding process. It was shown for the first time that the hexamer Aβ(37-42) is essential for the formation of β-sheets and subsequent fibrillization. As a final aspect, the elaboration of switch-peptides exhibiting β-breaking properties was investigated. Preliminary results indicate that one of the designed switch-peptides substantially slows down the formation of fibrils, representing a significant step in the development of therapeutically relevant compounds for the treatment of Alzheimer's disease. In conclusion, the elaborated methodologies allow for a general application of the switch concept as diagnostic tool in the study of fibrillogenesis.

EPFL2005

The Interplay between Cytidine Deaminases, HIV and Domesticated Genetic Parasites

"There is more virus in us than us in us". John Coffin's famous sentence illustrates that particular nucleic acid sequences related to exogenous viruses, called retrotransposons, constitute almost half of the human genome and largely exceeds the amount of protein-coding DNA (section 1.4). At the beginning of the past century, biologists realized the size of the genomes of various eukaryotes did not correlate with the level of complexity of these species. In extreme cases, certain species such as the fish L.paradoxa had 30-times more genomic DNA than do primates. In 1980, Francis Crick and Carmen Sapienza independently postulated that part of this once-called "junk DNA" must stem from self-replicating units, categorized as "selfish DNA" to distinguish them from more "altruistic" cellular genes. Indeed, while genes amplify in a population because of the selective advantage they confer to their host, the selfish DNA amplifies without making any contribution to the host phenotype and survives rather as a not-too-deleterious parasite. In early 2000's, the accomplishment of the human genome sequencing projects gave formal credence to Crick's and Sapienza's initial hypothesis. Retrotransposons replicate in the genome of their host by a copy-and-paste mechanism. Accordingly, any new retrotransposition event causes a genetic alteration potentially detrimental to the host. On an evolutionary perspective however, accumulation of retrotransposon-derived sequences can be beneficial to the species after these once "selfish" elements become "domesticated" to deserve more physiological roles. In human or mouse for instance, retrotransposons are known to cover a large spectrum of cellular functions, from gene regulation to antiviral defense (section 1.6). In order to maintain under tight control the balance between the good and adverse effects of retroelements, eukaryotes have evolved cellular defenses aimed at inhibiting the replication of such elements (section 1.7). Gene silencing by DNA methylation is a mechanism widely used in plants, fungi or vertebrates to control the expression of self-replicating elements. For instance in mammals, specific KRAB-zinc finger proteins can target retroviral-derived sequences and mediate their transcriptional silencing (section 3). The first aim of this study was to characterize the sensitivity of retroviruses to KRAB-mediated epigenetic silencing in varied chromosomal contexts (section 5). Since some retroviruses like HIV favor integration within transcriptionally active regions, these viruses may escape blockade by integrating chromosomal area refractory to epigenetic silencing. We found that instead, KRAB-mediated repression mechanism was not dependent upon integration site of a retroviral vector, hence the emergence of viruses escaping KRAB-mediated repression would be unlikely. Mammalian cells are also able to control the replication of retrotransposons at a post-transcriptional level via the APOBEC3 family of cytidine deaminases (section 2). Since certain retrotransposons are related to exogenous retroviruses, it is perhaps not surprising that APOBEC3 proteins can also inhibit a range of such elements including HIV. While there is only one APOBEC3 gene in the mouse genome, the family considerably expanded in other species such as primates were it comprises seven members (section 2.1). Although it is tempting to postulate that the expansion of the family in primates was driven by the strong selective pressure imposed by various genetic threats growing in number and complexity, it is not understood how only a few homologous proteins can target such a disparate group of replicating elements. The second aim of this study was to understand the mechanism by which different APOBEC3 proteins can target and inactivate particular self-perpetuating elements (section 4). We launched an integrative study focused on two human APOBEC3 homologues with distinct antiviral functions. APOBEC3A, a single-domain cytidine deaminase, can block efficiently the parvovirus adeno-associated virus type 2 (AAV-2) or the retrotransposon LINE-1 but cannot inhibit HIV replication. APOBEC3G is formed of two independent cytidine deaminase domains, only the C-terminal of which is catalytically active. APOBEC3G is endowed with restriction activity against HIV, but is largely ineffective against AAV-2 or LINE-1. We combined functional studies with structural modeling and phylogenetic analyses and found that restriction in each case involved similar regions at the surface of the protein and nearby the catalytic center, yet with distinct shapes and nucleic-acid interacting properties between the homologous proteins. While on APOBEC3G, the amino-acids in this region mediate intersubunit contacts between monomers and the predicted dimer interface shapes a groove that may facilitate binding to single-stranded RNA, on APOBEC3A however, it is corresponding residues on the monomer that form a DNA-binding groove important for editing. In summary, this study describes the nucleic-acid-interacting domains of APOBEC3A and APOBEC3G essential for their intrinsic restriction activities, and further suggests that structural variations in this domain may contribute to define the sets of targets inhibited by each APOBEC3 protein. APOBEC3 proteins may be considered as modular units, whose restriction function can evolve with emerging selective pressures by specific variations in their nucleic-acid binding domain, alternatively by fusion of two APOBEC3 proteins endowed with different functionalities. APOBEC3 proteins would efficiently protect the genome integrity of their host against highly variable genetic threats or "selfish DNA", in combination with other restriction factors such as the KRAB-zinc finger proteins. Contrary to epigenetic silencing however, post-transcriptional restriction as provided by APOBEC3 proteins may prohibit the deleterious effect of retrotransposition, without altering other retroelement functions putatively important for the physiology of the cell.

EPFL2010